Literature DB >> 19585539

Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.

Xiaodong Li1, Luke H Hoeppner, Eric D Jensen, Rajaram Gopalakrishnan, Jennifer J Westendorf.   

Abstract

Runx proteins are essential for a number of developmental processes and are aberrantly expressed in many human cancers. Runx factors bind DNA and co-factors to activate or repress genes crucial for bone formation, hematopoiesis, and neuronal development. Co-activator activator (CoAA) is a nuclear protein that regulates gene expression, RNA splicing and is overexpressed in many human tumors. In this study, we identified CoAA as a Runx2 binding protein. CoAA repressed Runx factor-dependent activation of reporter genes in a histone deacetylase-independent manner. CoAA also blocked Runx2-mediated repression of the Axin2 promoter, a novel Runx target gene. The carboxy-terminus of CoAA is essential for binding the Runt domains of Runx1 and Runx2. In electophoretic mobility shift assays, CoAA inhibited Runx2 interactions with DNA. These data indicate that CoAA is an inhibitor of Runx factors and can negate Runx factor regulation of gene expression. CoAA is expressed at high levels in human fetal osteoblasts and osteosarcoma cell lines. Suppression of CoAA expression by RNA interference reduced osteosarcoma cell viability in vitro, suggesting that it contributes to the proliferation and/or survival of osteoblast lineage cells. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585539      PMCID: PMC3876284          DOI: 10.1002/jcb.22263

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  56 in total

1.  Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation.

Authors:  Bo Liu; Hsiao-Man Ivy Yu; Wei Hsu
Journal:  Dev Biol       Date:  2006-10-21       Impact factor: 3.582

Review 2.  Runx2: a master organizer of gene transcription in developing and maturing osteoblasts.

Authors:  Tania M Schroeder; Eric D Jensen; Jennifer J Westendorf
Journal:  Birth Defects Res C Embryo Today       Date:  2005-09

Review 3.  Wnt/beta-catenin signaling in development and disease.

Authors:  Hans Clevers
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

4.  Histone deacetylase inhibitors promote osteoblast maturation.

Authors:  Tania M Schroeder; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2005-08-08       Impact factor: 6.741

5.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  The role of Axin2 in calvarial morphogenesis and craniosynostosis.

Authors:  Hsiao-Man Ivy Yu; Boris Jerchow; Tzong-Jen Sheu; Bo Liu; Frank Costantini; J Edward Puzas; Walter Birchmeier; Wei Hsu
Journal:  Development       Date:  2005-04       Impact factor: 6.868

7.  Identification and characterization of a protein containing formin homology (FH1/FH2) domains.

Authors:  J J Westendorf; R Mernaugh; S W Hiebert
Journal:  Gene       Date:  1999-05-31       Impact factor: 3.688

Review 8.  The RUNX genes: gain or loss of function in cancer.

Authors:  Karen Blyth; Ewan R Cameron; James C Neil
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

9.  Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.

Authors:  Rachel A Kahler; Mario Galindo; Jane Lian; Gary S Stein; Andre J van Wijnen; Jennifer J Westendorf
Journal:  J Cell Biochem       Date:  2006-04-01       Impact factor: 4.429

10.  The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.

Authors:  Michela Perani; Per Antonson; Rifat Hamoudi; Catherine J E Ingram; Colin S Cooper; Michelle D Garrett; Graham H Goodwin
Journal:  J Biol Chem       Date:  2005-10-14       Impact factor: 5.157

View more
  8 in total

1.  Knockdown of PRKAR1A, the gene responsible for Carney complex, interferes with differentiation in osteoblastic cells.

Authors:  Mei Zhang; Parmeet K Manchanda; Dayong Wu; Qianben Wang; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2014-02-07

2.  TEThered to Runx: novel binding partners for runx factors.

Authors:  Xiaodong Li; Matthew Decker; Jennifer J Westendorf
Journal:  Blood Cells Mol Dis       Date:  2010-04-01       Impact factor: 3.039

3.  The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation.

Authors:  Xiaodong Li; Meghan E McGee-Lawrence; Matthew Decker; Jennifer J Westendorf
Journal:  J Cell Biochem       Date:  2010-11-01       Impact factor: 4.429

4.  ODAM Expression Inhibits Human Breast Cancer Tumorigenesis.

Authors:  Daniel P Kestler; James S Foster; Charles T Bruker; John W Prenshaw; Stephen J Kennel; Jonathan S Wall; Deborah T Weiss; Alan Solomon
Journal:  Breast Cancer (Auckl)       Date:  2011-04-28

5.  Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice.

Authors:  Meghan E McGee-Lawrence; Xiaodong Li; Krista L Bledsoe; Hai Wu; John R Hawse; Malayannan Subramaniam; David F Razidlo; Bridget A Stensgard; Gary S Stein; Andre J van Wijnen; Jane B Lian; Wei Hsu; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

6.  The Role of RUNX2 in Osteosarcoma Oncogenesis.

Authors:  J W Martin; M Zielenska; G S Stein; A J van Wijnen; J A Squire
Journal:  Sarcoma       Date:  2010-12-09

7.  Regulation of zebrafish dorsoventral patterning by phase separation of RNA-binding protein Rbm14.

Authors:  Yue Xiao; Jiehui Chen; Yihan Wan; Qi Gao; Naihe Jing; Yixian Zheng; Xueliang Zhu
Journal:  Cell Discov       Date:  2019-07-23       Impact factor: 10.849

8.  The RBM14/CoAA-interacting, long intergenic non-coding RNA Paral1 regulates adipogenesis and coactivates the nuclear receptor PPARγ.

Authors:  François F Firmin; Frederik Oger; Céline Gheeraert; Julie Dubois-Chevalier; Anne-Sophie Vercoutter-Edouart; Fawaz Alzaid; Claire Mazuy; Hélène Dehondt; Jeremy Alexandre; Bruno Derudas; Quentin Dhalluin; Maheul Ploton; Alexandre Berthier; Eloise Woitrain; Tony Lefebvre; Nicolas Venteclef; François Pattou; Bart Staels; Jérôme Eeckhoute; Philippe Lefebvre
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.